Exceptional response to rechallenge of BRAF/MEK inhibitors in patients with primary acquired resistance to targeted therapy

• B. Ziółkowska,
• G. Kamińska-Winciorek,
• K. Galwas,
• R. Suwiński

Affiliations

B. Ziółkowska

Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 2nd Department of Radiotherapy and Chemotherapy, Gliwice, Poland

G. Kamińska-Winciorek

Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Department of Bone Marrow Transplantation and Oncohematology, Gliwice, Poland

K. Galwas

Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 2nd Department of Radiotherapy and Chemotherapy, Gliwice, Poland

R. Suwiński

Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 2nd Department of Radiotherapy and Chemotherapy, Gliwice, Poland